{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:00:41Z","timestamp":1794222041935,"version":"4.8.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10096-025-05101-z","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T01:00:31Z","timestamp":1742346031000},"page":"1505-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical characteristics and associated factors of macrolide-resistant mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"given":"Shuo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzheng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haokai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"12","key":"5101_CR1","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.rmed.2008.06.022","volume":"102","author":"A Defilippi","year":"2008","unstructured":"Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, Cirillo C, Di Pietro P, Rossi GA (2008) Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 102(12):1762\u20131768","journal-title":"Respir Med"},{"issue":"4","key":"5101_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1542\/peds.113.4.701","volume":"113","author":"IC Michelow","year":"2004","unstructured":"Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH Jr (2004) Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113(4):701\u2013707","journal-title":"Pediatrics"},{"issue":"4","key":"5101_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1442-200X.2008.02622.x","volume":"50","author":"K Azumagawa","year":"2008","unstructured":"Azumagawa K, Kambara Y, Murata T, Tamai H (2008) Four cases of arthritis associated with Mycoplasma pneumoniae infection. Pediatr Int 50(4):511\u2013513","journal-title":"Pediatr Int"},{"key":"5101_CR4","doi-asserted-by":"crossref","unstructured":"Metz G, Kraft M (2010) Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am 30(4):575\u2013585","DOI":"10.1016\/j.iac.2010.08.003"},{"issue":"6","key":"5101_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1086\/317498","volume":"31","author":"M Radisic","year":"2000","unstructured":"Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P (2000) Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis 31(6):1507\u20131511","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5101_CR6","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1086\/318446","volume":"32","author":"M Socan","year":"2001","unstructured":"Socan M, Ravnik I, Bencina D, Dovc P, Zakotnik B, Jazbec J (2001) Neurological symptoms in patients whose cerebrospinal fluid is culture- and\/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis 32(2):E31-35","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5101_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2010.03.004","volume":"67","author":"Y Liu","year":"2010","unstructured":"Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M (2010) Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 67(4):355\u2013358","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"5101_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","volume":"16","author":"R Dumke","year":"2010","unstructured":"Dumke R, von Baum H, L\u00fcck PC, Jacobs E (2010) Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 16(6):613\u2013616","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"5101_CR9","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1128\/AAC.00582-08","volume":"52","author":"BJ Wolff","year":"2008","unstructured":"Wolff BJ, Thacker WL, Schwartz SB, Winchell JM (2008) Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 52(10):3542\u20133549","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5101_CR10","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1128\/AAC.49.6.2302-2306.2005","volume":"49","author":"M Morozumi","year":"2005","unstructured":"Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, Kawamura N, Nakayama E, Tajima T, Shimizu K, Ubukata K (2005) Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 49(6):2302\u20132306","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5101_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","volume":"16","author":"M Morozumi","year":"2010","unstructured":"Morozumi M, Takahashi T, Ubukata K (2010) Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 16(2):78\u201386","journal-title":"J Infect Chemother"},{"issue":"1","key":"5101_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2958.2000.01841.x","volume":"36","author":"S Douthwaite","year":"2000","unstructured":"Douthwaite S, Hansen LH, Mauvais P (2000) Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 36(1):183\u2013193","journal-title":"Mol Microbiol"},{"key":"5101_CR13","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2021) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 23 Nov 2024"},{"key":"5101_CR14","unstructured":"Ma Q, Fu X, Liu X, Cui F, Xin D (2010) The relationship between the occurrence of extrapulmonary complications in mycoplasma pneumoniae pneumonia in children and drug resistance. Hebei Med J 32(24):3445\u20133446"},{"issue":"05","key":"5101_CR15","first-page":"18","volume":"22","author":"X Han","year":"2016","unstructured":"Han X, Wen H, Miao N, Wang C (2016) Drug resistance situation and clinical efficiency of azithromycin in children with Mycoplasma pneumoniae pneumonia. J Pediatr Pharm 22(05):18\u201320","journal-title":"J Pediatr Pharm"},{"key":"5101_CR16","unstructured":"Liu D, Zhang X, Li Y (2016) The infection of Mycoplasma pneumoniae, detection and analysis of drug resistance in children.\u00a0Med J West China\u00a028(11):1598\u20131602"},{"issue":"5","key":"5101_CR17","first-page":"357","volume":"11","author":"XLQ Feng","year":"2016","unstructured":"Feng X, Li Q, Sun L, Jiao WW, Xu BP, Yin Ju, Guo Y, Shen C, Li JQ (2016) The clinical characteristics of macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a case-control study. Chinese Journal of Evidence-Based Pediatrics 11(5):357\u2013360","journal-title":"Chinese Journal of Evidence-Based Pediatrics"},{"issue":"09","key":"5101_CR18","first-page":"1232","volume":"29","author":"MJXM Zhu","year":"2016","unstructured":"Zhu MJ, Xu M, Song L, Zhao JH, Zhou F, Ji JH (2016) Clinical analysis of drug-resistant Mycoplasma pneumoniae pneumonia in children.\u00a0Chin J Clin Res\u00a029(09):1232\u20131234","journal-title":"Chinese Journal of Clinical Research"},{"key":"5101_CR19","unstructured":"Kong J, Chen YJ, Guan MC, Hang JG, Peng CJ, Wang LH (2016) Clinical characteristics and IL-8 expression in bronchoalveolar lavage fLuid of mycoplasma pneumoniae pneumonia in children with MP 23S rRNA resistance gene 2063 locus positive. Chinese J Health Lab Technol 26(23):3385\u20133388"},{"issue":"21","key":"5101_CR20","first-page":"5313","volume":"32","author":"YHC Chen","year":"2017","unstructured":"Chen Y, Hu C (2017) Prevalence of macrolide resistance in children with Mycoplasma pneumoniae infection and the expression and significance of serum WBC, CRP, and ESR. Maternal & Child Health Care of China 32(21):5313\u20135316","journal-title":"Maternal & Child Health Care of China"},{"key":"5101_CR21","unstructured":"Yang YH, Zhang Y, Huang XM, Chen YL, Shen J, Zhang WY (2018) Clinic analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Chin J Gen Pract 16 (03):434\u2013436+491"},{"issue":"12","key":"5101_CR22","first-page":"48","volume":"25","author":"YCB Lu","year":"2018","unstructured":"Lu Y, Chen B, Wu M (2018) Detection and clinical significance of drug resistance genes in Mycoplasma pneumonia in children.\u00a0Chin J Rural Med Pharm\u00a025(12):48\u201349","journal-title":"Chinese Journal of Rural Medicine and Pharmacy"},{"issue":"8","key":"5101_CR23","first-page":"569","volume":"36","author":"YZL Li","year":"2018","unstructured":"Li Y, Zhong L, Zhang B, Huang H, Ding X, Lin L, Chen H, Huang Z, Peng L, Lin X (2018) Analysis of clinical features of children with Mycoplasma pneumoniae pneumonia with A 2063 G gene mutation in 23 S rRNA V domain.\u00a0J Clin Pediatr\u00a036(8):569\u2013574","journal-title":"Journal of Clinical Pediatrics"},{"issue":"8","key":"5101_CR24","first-page":"629","volume":"20","author":"YTW Chen","year":"2018","unstructured":"Chen Y, Tian W, Chen Q, Zhao H, Huang P, Lin Z, Chen L (2018) Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Chinese Journal of Contemporary Pediatrics 20(8):629\u2013634","journal-title":"Chinese Journal of Contemporary Pediatrics"},{"issue":"12","key":"5101_CR25","first-page":"1850","volume":"29","author":"CHX Chen","year":"2019","unstructured":"Chen C, Huang X, Zhao D, Xie Y, Wu P, Deng L, Lu G (2019) Surveillance of Mycoplasma pneumoniae antibiotic resistance in children from 2014 to 2018.\u00a0Chin J Sociol 29(12):1850\u20131855","journal-title":"Chinese Journal of Nosocomiology"},{"issue":"08","key":"5101_CR26","first-page":"626","volume":"35","author":"BZL Wu","year":"2020","unstructured":"Wu B, Zhang L, Zhang W, Li X, Liu J, Gu Q (2020) Detection and clinical analysis of drug-resistant mutation sites in children with Mycoplasma infectious lobar pneumonia.\u00a0Chin J Pract Pediatr\u00a035(08):626\u2013630","journal-title":"Chinese Journal of Practical Pediatrics"},{"issue":"9","key":"5101_CR27","first-page":"1385","volume":"25","author":"X Chen","year":"2020","unstructured":"Chen X, Wang J, Hong Y, Zhang L (2020) Risk factors for MA resistance in children with Mycoplasma pneumoniae pneumonia and suggestions for treatment. Journal of Clinical Pulmonary Medicine 25(9):1385\u20131388","journal-title":"Journal of Clinical Pulmonary Medicine"},{"issue":"4","key":"5101_CR28","first-page":"265","volume":"39","author":"CLW Yu","year":"2021","unstructured":"Yu C, Lv W, Zhang X (2021) The relationship between clinical phenotype and chest imaging in community-acquired pneumonia with MP 23S rRNA A2063G gene mutation in children.\u00a0J Clin Pediatr\u00a039(4):265\u2013268","journal-title":"Journal of Clinical Pediatrics"},{"issue":"04","key":"5101_CR29","first-page":"603","volume":"19","author":"CWA Wu","year":"2021","unstructured":"Wu C, Wang A, Cai Z (2021) Correlation between 23S rRNA mutation of Mycoplasma pneumoniae and clinical characteristics and drug resistance in children. Chinese Journal of General Practice 19(04):603\u2013606","journal-title":"Chinese Journal of General Practice"},{"issue":"07","key":"5101_CR30","first-page":"924","volume":"29","author":"LWX Ren","year":"2021","unstructured":"Ren L, Wang X, Zhao T, Liu R (2021) Study on the relationship between the 2063 site mutation of 23S rRNA resistance gene and MP-DNA load and resistance to macrolides in children with MPP.\u00a0Chin J Birth Health Heredity\u00a029(07):924\u2013927","journal-title":"Chinese Journal of Birth Health & Heredity"},{"issue":"08","key":"5101_CR31","first-page":"36","volume":"28","author":"JZX He","year":"2022","unstructured":"He J, Zhang X, Zhao W, Yang L (2022) Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. J Pediatr Pharm 28(08):36\u201339","journal-title":"J Pediatr Pharm"},{"issue":"15","key":"5101_CR32","first-page":"1836","volume":"32","author":"BQJ Guo","year":"2022","unstructured":"Guo B, Qiao J, Pang X, Li H, Hou Y, Tian J (2022) Correlation and analysis between 23S rRNA gene mutation and antibiotic resistance of Mycoplasma pneumoniae in children.\u00a0Chin J Health Lab Technol 32(15):1836\u20131839","journal-title":"Chinese Journal of Health Laboratory Technology"},{"issue":"05","key":"5101_CR33","first-page":"376","volume":"38","author":"YMC Zhang","year":"2023","unstructured":"Zhang Y, Meng C (2023) Analysis of gene mutation of macrolides resistance in children with refractory Mycoplasma pneumoniae pneumonia.\u00a0Chin J Pract Pediatr\u00a038(05):376\u2013380","journal-title":"Chinese Journal of Practical Pediatrics"},{"issue":"9","key":"5101_CR34","first-page":"1021","volume":"58","author":"J Peng","year":"2023","unstructured":"Peng J, Wang Y (2023) Multifactorial analysis of clinical indicators associated with macrolide resistant Mycoplasma pneumoniae infection in children. Chinese Journal of Medicine 58(9):1021\u20131023","journal-title":"Chinese Journal of Medicine"},{"issue":"8","key":"5101_CR35","first-page":"65","volume":"21","author":"P Chen","year":"2023","unstructured":"Chen P, Liu W (2023) Analysis of risk factors and construction of risk assessment model for macrolide antibiotics resistance in children with Mycoplasma pneumonia. Clinical Medication Journal 21(8):65\u201370","journal-title":"Clinical Medication Journal"},{"issue":"14","key":"5101_CR36","first-page":"1673","volume":"33","author":"JYC Zhou","year":"2023","unstructured":"Zhou J, Yuan C (2023) Resistance gene mutations and characteristics of Mycoplasma pneumoniae in children.\u00a0Chin J Health Lab Technol 33(14):1673\u20131676","journal-title":"Chinese Journal of Health Laboratory Technology"},{"issue":"11","key":"5101_CR37","first-page":"822","volume":"36","author":"WZX Zhang","year":"2021","unstructured":"Zhang W, Zhang X, Gu W, Yan Y, Ji W, Zhu C, Shao X, Hao C, Chen Z (2021) Role of macrolides resistance in children with refractory Mycoplasma pneumoniae pneumonia.\u00a0Chin J Appl Clin Pediatr\u00a036(11):822\u2013826","journal-title":"Chinese Journal of Applied Clinical Pediatrics"},{"issue":"12","key":"5101_CR38","first-page":"897","volume":"37","author":"JZH Chen","year":"2022","unstructured":"Chen J, Zhang H, Shang Y (2022) Clinical and bronchoscopy characteristics of Mycoplasma pneumoniae pneumonia in children with 23S rRNA resistance gene positive in bronchoalveolar lavage fluid.\u00a0Chin J Appl Clin Pediatr\u00a037(12):897\u2013902","journal-title":"Chinese Journal of Applied Clinical Pediatrics"},{"issue":"10","key":"5101_CR39","first-page":"735","volume":"32","author":"BYC Zheng","year":"2017","unstructured":"Zheng B, Yan C, Xue G, Cao L, Sun H (2017) Analysis of clinical characteristics and epidemic genotypes of children with Mycoplasma pneumoniae pneumonia.\u00a0Chin J Appl Clin Pediatr\u00a032(10):735\u2013739","journal-title":"Chinese Journal of Applied Clinical Pediatrics"},{"issue":"10","key":"5101_CR40","first-page":"756","volume":"36","author":"FQJ Bao","year":"2013","unstructured":"Bao F, Qu JX, Liu ZJ, Qin XG, Cao B (2013) The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Chinese Journal of Tuberculosis and Respiratory Diseases 36(10):756\u2013761","journal-title":"Chinese Journal of Tuberculosis and Respiratory Diseases"},{"issue":"9","key":"5101_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ppul.22706","volume":"48","author":"PS Wu","year":"2013","unstructured":"Wu PS, Chang LY, Lin HC, Chi H, Hsieh YC, Huang YC, Liu CC, Huang YC, Huang LM (2013) Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Pediatr Pulmonol 48(9):904\u2013911","journal-title":"Pediatr Pulmonol"},{"key":"5101_CR42","doi-asserted-by":"crossref","unstructured":"Kuo CY, Tsai WC, Lee HF, Ho TS, Huang LM, Shen CF, Liu CC (2022) The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019\u20132020. J Microbiol Immunol Infect = Wei mian yu gan ran za zhi 55(4):611\u2013619","DOI":"10.1016\/j.jmii.2021.09.010"},{"issue":"2","key":"5101_CR43","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","volume":"58","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z (2014) More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 58(2):1034\u20131038","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5101_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ppul.22851","volume":"49","author":"Z Ma","year":"2014","unstructured":"Ma Z, Zheng Y, Deng J, Ma X, Liu H (2014) Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China. Pediatric pulmonology 49(7):695\u2013700","journal-title":"Pediatric pulmonology"},{"issue":"6","key":"5101_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","volume":"15","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S (2009) A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. Journal of infection and chemotherapy\u202f: official journal of the Japan Society of Chemotherapy 15(6):380\u2013383","journal-title":"Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"},{"key":"5101_CR46","doi-asserted-by":"crossref","unstructured":"Cheong KN, Chiu SS, Chan BW, To KK, Chan EL, Ho PL (2016) Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure. J Microbiol Immunol Infect = Wei mian yu gan ran za zhi 49 (1):127\u2013130","DOI":"10.1016\/j.jmii.2014.11.003"},{"issue":"12","key":"5101_CR47","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1097\/INF.0b013e3182a25c71","volume":"32","author":"DC Lung","year":"2013","unstructured":"Lung DC, Yip EK, Lam DS, Que TL (2013) Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Pediatr Infect Dis J 32(12):1396\u20131399","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"5101_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/JCM.02840-12","volume":"51","author":"F Cardinale","year":"2013","unstructured":"Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S (2013) Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol 51(2):723\u2013724","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5101_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jgf2.201","volume":"19","author":"Y Akashi","year":"2018","unstructured":"Akashi Y, Hayashi D, Suzuki H, Shiigai M, Kanemoto K, Notake S, Ishiodori T, Ishikawa H, Imai H (2018) Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae. Journal of general and family medicine 19(6):191\u2013197","journal-title":"Journal of general and family medicine"},{"issue":"3","key":"5101_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173635","volume":"12","author":"N Ishiguro","year":"2017","unstructured":"Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Togashi T, Oba K, Morita K, Nagano N, Nakanishi M, Hara K, Hazama K, Watanabe T, Yamanaka T, Sasaki S, Furuyama H, Shibata M, Shida S, Ishizaka A, Tabata Y, Aoyagi H, Naito H, Yoshioka M, Horino A, Kenri T (2017) Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. PLoS ONE 12(3):e0173635","journal-title":"PLoS ONE"},{"key":"5101_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-126","volume":"12","author":"N Miyashita","year":"2012","unstructured":"Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, Okimoto N (2012) Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis 12:126","journal-title":"BMC Infect Dis"},{"issue":"12","key":"5101_CR52","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","volume":"55","author":"T Okada","year":"2012","unstructured":"Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K (2012) Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clinical infectious diseases\u202f: an official publication of the Infectious Diseases Society of America 55(12):1642\u20131649","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"5101_CR53","doi-asserted-by":"crossref","unstructured":"Kim JH, Kim JY, Yoo CH, Seo WH, Yoo Y, Song DJ, Choung JT (2017) Macrolide resistance and its impacts on M. pneumoniae pneumonia in children: comparison of two recent epidemics in Korea. Allergy Asthma Immunol Res 9(4):340\u2013346","DOI":"10.4168\/aair.2017.9.4.340"},{"issue":"10","key":"5101_CR54","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3346\/jkms.2017.32.10.1642","volume":"32","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Shin KS, Lee KH, Kim YR, Choi JH (2017) Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae from children in Jeju. J Korean Med Sci 32(10):1642\u20131646","journal-title":"J Korean Med Sci"},{"issue":"5","key":"5101_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","volume":"60","author":"E Lee","year":"2017","unstructured":"Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J (2017) Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr 60(5):151\u2013157","journal-title":"Korean J Pediatr"},{"issue":"4","key":"5101_CR56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3345\/kjp.2014.57.4.186","volume":"57","author":"YH Seo","year":"2014","unstructured":"Seo YH, Kim JS, Seo SC, Seo WH, Yoo Y, Song DJ, Choung JT (2014) Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Korean J Pediatr 57(4):186\u2013192","journal-title":"Korean J Pediatr"},{"issue":"12","key":"5101_CR57","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1128\/AAC.01421-12","volume":"56","author":"SJ Yoo","year":"2012","unstructured":"Yoo SJ, Kim HB, Choi SH, Lee SO, Kim SH, Hong SB, Sung H, Kim MN (2012) Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance. Antimicrob Agents Chemother 56(12):6393\u20136396","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5101_CR58","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s10156-012-0523-3","volume":"19","author":"HM Wu","year":"2013","unstructured":"Wu HM, Wong KS, Huang YC, Lai SH, Tsao KC, Lin YJ, Lin TY (2013) Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan. Journal of infection and chemotherapy\u202f: official journal of the Japan Society of Chemotherapy 19(4):782\u2013786","journal-title":"Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"},{"key":"5101_CR59","doi-asserted-by":"crossref","unstructured":"Yang TI, Chang TH, Lu CY, Chen JM, Lee PI, Huang LM, Chang LY (2019) Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter? J Microbiol Immunol Infect 52(2):329\u2013335","DOI":"10.1016\/j.jmii.2018.09.009"},{"issue":"9","key":"5101_CR60","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s10096-024-04902-y","volume":"43","author":"M Yan","year":"2024","unstructured":"Yan M, Tao R, Li S, Xiong J, Xiang J (2024) Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. European journal of clinical microbiology & infectious diseases\u202f: official publication of the European Society of Clinical Microbiology 43(9):1825\u20131835","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"issue":"1","key":"5101_CR61","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L (2024) Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep 14(1):5632","journal-title":"Sci Rep"},{"key":"5101_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1181402","volume":"13","author":"TT Jiang","year":"2023","unstructured":"Jiang TT, Sun L, Wang TY, Qi H, Tang H, Wang YC, Han Q, Shi XQ, Bi J, Jiao WW, Shen AD (2023) The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front Cell Infect Microbiol 13:1181402","journal-title":"Front Cell Infect Microbiol"},{"key":"5101_CR63","doi-asserted-by":"crossref","unstructured":"Yen MH, Yan DC, Wang CJ, Tsao KC, Huang YC, Cheng SW, Chiu CH, Huang YC, Lin TY (2023) The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: a retrospective study. J Microbiol Immunol Infect 56(3):634\u2013640","DOI":"10.1016\/j.jmii.2023.01.010"},{"issue":"1","key":"5101_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"XW Zhan","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, Zhang J, Wang MZ, Li SJ (2022) Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr 48(1):190","journal-title":"Ital J Pediatr"},{"issue":"10","key":"5101_CR65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.47102\/annals-acadmedsg.2022213","volume":"51","author":"J Li","year":"2022","unstructured":"Li J, Maiwald M, Loo LH, Soong HY, Octavia S, Thoon KC, Chong CY (2022) Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae infections among hospitalised children in Singapore. Ann Acad Med Singapore 51(10):653\u2013656","journal-title":"Ann Acad Med Singapore"},{"issue":"11","key":"5101_CR66","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/crj.13549","volume":"16","author":"M Sung","year":"2022","unstructured":"Sung M, Roh EJ, Lee ES, Lee JY, Kim HB, Ahn Y, Eun BW, Kim JK, Kim HY, Jung SS, Kim M, Kang EK, Yang EA, Lee SJ, Park Y, Seo JH, Lee E, Yang ES, Cho HM, Shin M, Chung HL, Jang YY, Choi BS, Kim H, Jung JA, You ST, Lee MH, Kim JT, Kim BS, Hwang YH, Shim JY, Yang HJ, Han MY, Yew HY, Kim DH, Jeong SO, Whang K, Lee E, Jeon YH, Chung EH (2022) Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia. Clin Respir J 16(11):756\u2013767","journal-title":"Clin Respir J"},{"issue":"5","key":"5101_CR67","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.pedneo.2021.05.017","volume":"62","author":"CH Chang","year":"2021","unstructured":"Chang CH, Tsai CK, Tsai TA, Wang SC, Lee YC, Tsai CM, Liu TY, Kuo KC, Chen CC, Yu HR (2021) Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan. Pediatr Neonatol 62(5):536\u2013542","journal-title":"Pediatr Neonatol"},{"issue":"6","key":"5101_CR68","doi-asserted-by":"publisher","first-page":"300060521101637","DOI":"10.1177\/03000605211016376","volume":"49","author":"C Xu","year":"2021","unstructured":"Xu C, Deng H, Zhang J, Zhu Y, Rong Q, Quan Y, Tang H, Zhao D (2021) Mutations in domain V of Mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China. The Journal of international medical research 49(6):3000605211016376","journal-title":"The Journal of international medical research"},{"issue":"6","key":"5101_CR69","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3201\/eid2706.203206","volume":"27","author":"MM Lanata","year":"2021","unstructured":"Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A (2021) Macrolide-resistant Mycoplasma pneumoniae infections in children, Ohio, USA. Emerg Infect Dis 27(6):1588\u20131597","journal-title":"Emerg Infect Dis"},{"key":"5101_CR70","unstructured":"Chen F, Zhang F (2024) Early clinical characteristics and related risk factors of refractory Mycoplasma pneumoniae pneumonia in children. China Trop Med 24(07):777\u2013782"},{"key":"5101_CR71","unstructured":"Li J, Ma Y, Yin J, Ming Z (2024) Study on the relationship between Mycoplasma pneumoniae resistance and refractory Mycoplasma pneumoniae pneumonia in children. J North China Univ Sci Technol (Health Sciences Edition) 26(04):279\u2013282+290"},{"issue":"07","key":"5101_CR72","first-page":"64","volume":"31","author":"ZYZ Hu","year":"2023","unstructured":"Hu Z, Yang Z (2023) Relationship between drug sensitivity of Mycoplasma pneumoniae and incidence of refractory Mycoplasma pneumoniae pneumonia in children. China Medical Engineering 31(07):64\u201368","journal-title":"China Medical Engineering"},{"issue":"12","key":"5101_CR73","first-page":"1434","volume":"28","author":"LLM Chen","year":"2018","unstructured":"Chen L, Lin M, Shi L, Yu J (2018) Clinical correlation of Mycoplasma pneumoniae pneumonia in infants and young children with 23S rRNA gene mutation of Mycoplasma pneumoniae.\u00a0Chin J Health Lab Technol\u00a028(12):1434\u20131436","journal-title":"Chinese Journal of Health Laboratory Technology"},{"issue":"16","key":"5101_CR74","first-page":"1213","volume":"25","author":"DWS Xin","year":"2010","unstructured":"Xin D, Wang S, Han X, Ma S, Chen X (2010) Clinical characteristics of children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Chinese Journal of Applied Clinical Pediatrics 25(16):1213\u20131215","journal-title":"Chinese Journal of Applied Clinical Pediatrics"},{"issue":"3","key":"5101_CR75","first-page":"182","volume":"42","author":"YTYF Gu","year":"2024","unstructured":"Gu YT, Yang F, Ye JM, Hua L, Li J, Ding GD (2024) Macrolide resistance in hospitalized children with Mycoplasma pneumoniae pneumonia and its clinical diagnosis and treatment. Journal of Clinical Pediatrics 42(3):182\u2013186","journal-title":"Journal of Clinical Pediatrics"},{"issue":"4","key":"5101_CR76","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4168\/aard.2023.11.4.187","volume":"11","author":"E Lee","year":"2023","unstructured":"Lee E, Kim S-H (2023) Comparison of the characteristics of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae pneumonia requiring hospitalization in children. Allergy Asthma Respir Dis 11(4):187\u2013192","journal-title":"Allergy Asthma Respir Dis"},{"key":"5101_CR77","doi-asserted-by":"crossref","unstructured":"Wu TH, Wang NM, Liu FC, Pan HH, Huang FL, Fang YP, Chiang TW, Yang YY, Song CS, Wu HC, Lee CY (2021) Macrolide resistance, clinical features, and cytokine profiles in Taiwanese children with Mycoplasma pneumoniae infection. Open Forum Infect Dis 8(9):ofab416","DOI":"10.1093\/ofid\/ofab416"},{"issue":"1","key":"5101_CR78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0300060517716312","volume":"46","author":"H Deng","year":"2018","unstructured":"Deng H, Rui J, Zhao D, Liu F (2018) Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia. J Int Med Res 46(1):150\u2013157","journal-title":"J Int Med Res"},{"key":"5101_CR79","doi-asserted-by":"crossref","unstructured":"Contes KM, Liu BM (2024) Epidemiology, clinical significance and diagnosis of respiratory viruses and their Co-Infections in the Post-COVID Era. Preprints. Preprints","DOI":"10.20944\/preprints202412.0268.v1"},{"key":"5101_CR80","doi-asserted-by":"crossref","unstructured":"Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP (2019) Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol 57(11):10-1128","DOI":"10.1128\/JCM.00968-19"},{"key":"5101_CR81","first-page":"197","volume":"29","author":"R Dumke","year":"2014","unstructured":"Dumke R, Stolz S, Jacobs E, Juretzek T (2014) Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. International journal of infectious diseases\u202f: IJID\u202f: official publication of the International Society for Infectious Diseases 29:197\u2013199","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"issue":"9","key":"5101_CR82","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/nar\/30.9.2031","volume":"30","author":"EP Rocha","year":"2002","unstructured":"Rocha EP, Blanchard A (2002) Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution. Nucleic Acids Res 30(9):2031\u20132042","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5101_CR83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3201\/eid2801.210497","volume":"28","author":"YC Hsieh","year":"2022","unstructured":"Hsieh YC, Li SW, Chen YY, Kuo CC, Chen YC, Chang IY, Pan YJ, Li TH, Chiang RL, Huang YY, Liao WC (2022) Global Genome Diversity and Recombination in Mycoplasma pneumoniae. Emerg Infect Dis 28(1):111\u2013117","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"5101_CR84","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","volume":"26","author":"YC Chen","year":"2020","unstructured":"Chen YC, Hsu WY, Chang TH (2020) Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired Pneumonia. Emerg Infect Dis 26(7):1382\u20131391","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5101_CR85","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1186\/s12879-019-4667-y","volume":"19","author":"J Liu","year":"2019","unstructured":"Liu J, Zhao F, Lu J, Xu H, Liu H, Tang X, Yang H, Zhang J, Zhao S (2019) High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia. BMC Infect Dis 19(1):1045","journal-title":"BMC Infect Dis"},{"key":"5101_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102095","volume":"71","author":"J Pollock","year":"2021","unstructured":"Pollock J, Chalmers JD (2021) The immunomodulatory effects of macrolide antibiotics in respiratory disease. Pulm Pharmacol Ther 71:102095","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"5101_CR87","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","volume":"68","author":"P Zarogoulidis","year":"2012","unstructured":"Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K (2012) Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol 68(5):479\u2013503","journal-title":"Eur J Clin Pharmacol"},{"key":"5101_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00302","volume":"9","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Ziesenitz VC, Curtis N, Ritz N (2018) The immunomodulatory effects of macrolides-A systematic review of the underlying mechanisms. Front Immunol 9:302","journal-title":"Front Immunol"},{"issue":"3","key":"5101_CR89","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/1061186X.2024.2424895","volume":"33","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Khoshrou A, Eshaghian S, Karav S, Sahebkar A (2025) Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing. J Drug Target 33(3):341\u2013367","journal-title":"J Drug Target"},{"key":"5101_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100948","volume":"68","author":"M Abavisani","year":"2023","unstructured":"Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A (2023) CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug resistance updates\u202f: reviews and commentaries in antimicrobial and anticancer chemotherapy 68:100948","journal-title":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05101-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05101-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05101-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:51:17Z","timestamp":1748343077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05101-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05101-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}